🇺🇸 FDA
Patent

US 10400031

Identification of antibodies specific for lyssaviruses and methods of their use

granted A61KA61K2039/505

Quick answer

US patent 10400031 (Identification of antibodies specific for lyssaviruses and methods of their use) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
Grant date
Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505